https://www.selleckchem.com/products/brd3308.html
Histologic rejection, UTI, and asymptomatic bacteriuria (AS were present in 23 (50%), 9 (20%), and 16 (35%). Multivariate Cox proportional hazards models comparing KT recipients with or without HAGPN (n=46 and n=138, respectively) showed that HAGPN was associated with urologic complication by day 30, delayed graft function, previous UTI or ASB, and a history of rejection. In the univariate and multivariate analyses, HAGPN was associated with an increased risk of graft loss. HAGPN is an infrequent, unanticipated, and clinically signifi